CLINICAL_TRIALS
trial_result
· 2017-05-09
Clinical Trial Update: Geodon in Weight Loss Study for Bipolar Disorders [Phase 4]
Summary
Phase 4 trial update indicating ziprasidone (Geodon) was studied for weight loss in bipolar disorder, with results posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Stanford University | Conditions: Bipolar Disorder | Phase 4 | Status: COMPLETED | Results posted: 2017-05-09